14-90902969-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004755.4(RPS6KA5):āc.958A>Gā(p.Lys320Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000994 in 1,609,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004755.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS6KA5 | NM_004755.4 | c.958A>G | p.Lys320Glu | missense_variant, splice_region_variant | 9/17 | ENST00000614987.5 | NP_004746.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS6KA5 | ENST00000614987.5 | c.958A>G | p.Lys320Glu | missense_variant, splice_region_variant | 9/17 | 1 | NM_004755.4 | ENSP00000479667 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248070Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134056
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1456878Hom.: 0 Cov.: 31 AF XY: 0.00000414 AC XY: 3AN XY: 724572
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.958A>G (p.K320E) alteration is located in exon 9 (coding exon 9) of the RPS6KA5 gene. This alteration results from a A to G substitution at nucleotide position 958, causing the lysine (K) at amino acid position 320 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at